Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
2011 ◽
Vol 98
(4)
◽
pp. 493-502
◽
Keyword(s):
1993 ◽
Vol 13
(5)
◽
pp. 341-350
◽
2002 ◽
Vol 64
(6)
◽
pp. 2544-2551
◽
2006 ◽
Vol 147
(3)
◽
pp. 316-323
◽
1989 ◽
Vol 264
(31)
◽
pp. 18552-18560
◽
1980 ◽
Vol 5
(1)
◽
pp. 18-21
◽
2012 ◽
Vol 101
(7)
◽
pp. 2048-2050
◽